Jaren Madden

Investor Relations Contact at SCHRÖDINGER, INC.

Health Technology

Consumer Services

Commercial Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Ramy Farid	M	59	SCHRÖDINGER, INC.	22 years
Michael Lynton	M	64	SCHRÖDINGER, INC.	6 years
Yvonne Tran	F	53	SCHRÖDINGER, INC.	14 years
Arun Oberoi	M	70	SCHRÖDINGER, INC.	2 years
Frank Taffy	M	-	SCHRÖDINGER, INC.	3 years
Jeffrey Chodakewitz	M	68	SCHRÖDINGER, INC.	4 years
Nancy Thornberry	F	67	SCHRÖDINGER, INC.	5 years
Jenny Herman	F	-	SCHRÖDINGER, INC.	-
Richard Friesner	M	71	SCHRÖDINGER, INC.	34 years
Shane Brauner	M	47	SCHRÖDINGER, INC.	15 years
Rosana Kapeller-Libermann	M	60	SCHRÖDINGER, INC.	5 years
Gary Sender	M	62	SCHRÖDINGER, INC.	5 years
Gary Ginsberg	M	61	SCHRÖDINGER, INC.	4 years
Norman Selby	M	71	INFINITY PHARMACEUTICALS, INC.	12 years
Patrick Lorton	M	40	SCHRÖDINGER, INC.	18 years
Margaret Dugan	M	67	SCHRÖDINGER, INC.	1 years
Allie Nicodermo	F	-	SCHRÖDINGER, INC.	-
Mathew Halls	M	-	SCHRÖDINGER, INC.	12 years
Karen Akinsanya	M	56	SCHRÖDINGER, INC.	6 years
Robert Abel	M	42	SCHRÖDINGER, INC.	15 years
Paul Davie	M	-	SCHRÖDINGER, INC.	7 years
Geoffrey Porges	M	63	SCHRÖDINGER, INC.	2 years
Jean Lachowicz	M	-	SCHRÖDINGER, INC.	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Lawrence Bloch	M	58	INFINITY PHARMACEUTICALS, INC.	11 years
Christopher M. Lindblom	M	52	INFINITY PHARMACEUTICALS, INC.	8 years
Gerald Quirk	M	56	INFINITY PHARMACEUTICALS, INC.	6 years
Thomas Lynch	M	63	INFINITY PHARMACEUTICALS, INC.	5 years
José Baselga	M	65	INFINITY PHARMACEUTICALS, INC.	3 years
Gwen A. Fyfe	M	72	INFINITY PHARMACEUTICALS, INC.	4 years
Patrick Lee	M	67	INFINITY PHARMACEUTICALS, INC.	7 years
Joel Lebowitz	M	60	SCHRÖDINGER, INC.	4 years
Vito Palombella	M	61	INFINITY PHARMACEUTICALS, INC.	12 years
Dave Grayzel	M	56	INFINITY PHARMACEUTICALS, INC.	8 years
Timothy M. Wright	M	69	SCHRÖDINGER, INC.	6 years
Jeffrey Berkowitz	M	58	INFINITY PHARMACEUTICALS, INC.	6 years
Steven Holtzman	M	70	INFINITY PHARMACEUTICALS, INC.	17 years
Eric S. Lander	M	67	INFINITY PHARMACEUTICALS, INC.	10 years
Franklin H. Moss	M	75	INFINITY PHARMACEUTICALS, INC.	10 years
Martin Babler	M	59	INFINITY PHARMACEUTICALS, INC.	6 years
Michael Ferraresso	M	-	INFINITY PHARMACEUTICALS, INC.	4 years
Jeffery L. Kutok	M	57	INFINITY PHARMACEUTICALS, INC.	10 years
Michael Landsittel	M	52	INFINITY PHARMACEUTICALS, INC.	-
Joseph Pearlberg	M	60	INFINITY PHARMACEUTICALS, INC.	3 years
James Tananbaum	M	60	INFINITY PHARMACEUTICALS, INC.	6 years
Jayne Kauffman	F	-	INFINITY PHARMACEUTICALS, INC.	-
David Roth	M	61	INFINITY PHARMACEUTICALS, INC.	2 years
Patrick F. Kelly	M	60	INFINITY PHARMACEUTICALS, INC.	3 years
Ronald Vigliotta	M	51	INFINITY PHARMACEUTICALS, INC.	7 years
Deborah Miller	M	48	INFINITY PHARMACEUTICALS, INC.	7 years
Scott Barrett	M	61	INFINITY PHARMACEUTICALS, INC.	2 years
James Porter	M	48	INFINITY PHARMACEUTICALS, INC.	14 years
Jennifer Schranz	M	59	Shire Plc /Old/ Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986	4 years
John Lee	M	56	INFINITY PHARMACEUTICALS, INC.	15 years
Colleen Wilson	F	47	INFINITY PHARMACEUTICALS, INC.	2 years
Elizabeth G. Trehu	M	64	INFINITY PHARMACEUTICALS, INC.	2 years
Winston K. C. Lam	M	-	INFINITY PHARMACEUTICALS, INC.	-
Tamyra A. Toole	F	-	INFINITY PHARMACEUTICALS, INC.	9 years
Winselow Tucker	M	56	INFINITY PHARMACEUTICALS, INC.	-
William Bertrand	M	59	INFINITY PHARMACEUTICALS, INC.	1 years
Jeanette W. Kohlbrenner	F	-	INFINITY PHARMACEUTICALS, INC.	10 years
Joshua D. Hamermesh	M	51	INFINITY PHARMACEUTICALS, INC.	3 years
Harry F. Hixson	M	84	INFINITY PHARMACEUTICALS, INC.	9 years
Pedro D. Santabarbara	M	71	INFINITY PHARMACEUTICALS, INC.	4 years
Arnold Levine	M	84	INFINITY PHARMACEUTICALS, INC.	6 years
Sujay Kango	M	60	INFINITY PHARMACEUTICALS, INC.	2 years
Tracy Lessor	M	-	SCHRÖDINGER, INC.	2 years

Statistics

Country	Connections	% of total
United States	65	98.48%
United Kingdom	1	1.52%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections